Laura Baker, PhD from the Wake Forest School of Medicine, Winston-Salem, NC describes the ideal patient for the U.S. POINTER study at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK. She explains how the trial is ideal for people who have room for improvement regarding how well they look after their body. If someone is already exercising, eating well and has no co-morbidities then this trial will not benefit them any further. She provides a very effective analogy on how the body is a machine that needs to be well looked after in order to prevent deterioration.
